Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome

Molecular and Cellular Endocrinology

Volumn 418, Issue , 2015, Pages 306-321

  Hevener, Andrea L ^a   Clegg, Deborah J ^b   Mauvais Jarvis, Franck ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Estrogen action; Insulin resistance; Metabolic syndrome; Obesity

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA, HUMAN;

ADIPOSE TISSUE; BODY FAT DISTRIBUTION; CALORIC INTAKE; CELL FUNCTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASES; ENERGY EXPENDITURE; FATTY ACID METABOLISM; GENETIC REGULATION; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN SENSITIVITY; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR SENSITIVITY; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TISSUE DISTRIBUTION; WOMEN'S HEALTH; ANIMAL; ANTIBODY SPECIFICITY; ENERGY METABOLISM; FEMALE; INSULIN RESISTANCE; METABOLISM; MOTOR ACTIVITY;

ANIMALS; ENERGY METABOLISM; ESTROGEN RECEPTOR ALPHA; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MOTOR ACTIVITY; ORGAN SPECIFICITY; WOMEN'S HEALTH;

EID: 84949254798     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.05.020     Document Type: Review

References (272)

1. Adams J.M., Pratipanawatr T., Berria R., Wang E., DeFronzo R.A., Sullards M.C., et al. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 2004, 53(1):25-31.
2. Ainslie D.A., Morris M.J., Wittert G., Turnbull H., Proietto J., Thorburn A.W. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y. Int. J. Obes. Relat. Metab. Disord 2001, 25(11):1680-1688.
3. Alonso A., Ordonez P., Fernandez R., Moreno M., Llaneza P., Patterson A.M., et al. 17beta-estradiol treatment is unable to reproduce p85 alpha redistribution associated with gestational insulin resistance in rats. J. Steroid Biochem. Mol. Biol 2009, 116(3-5):160-170.
4. Alonso A., Gonzalez-Pardo H., Garrido P., Conejo N.M., Llaneza P., Diaz F., et al. Acute effects of 17 beta-estradiol and genistein on insulin sensitivity and spatial memory in aged ovariectomized female rats. Age (Dordr) 2010, 32(4):421-434. PMCID: 2980599.
5. Alonso-Magdalena P., Ropero A.B., Carrera M.P., Cederroth C.R., Baquie M., Gauthier B.R., et al. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS ONE 2008, 3(4):e2069. PMCID: 2323613.
6. Amati F., Dube J.J., Alvarez-Carnero E., Edreira M.M., Chomentowski P., Coen P.M., et al. Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?. Diabetes 2011, 60(10):2588-2597. PMCID: 3178290.
7. Atwater I., Gondos B., DiBartolomeo R., Bazaes R., Jovanovic L. Pregnancy hormones prevent diabetes and reduce lymphocytic infiltration of islets in the NOD mouse. Ann. Clin. Lab. Sci 2002, 32(1):87-92.
8. Balhuizen A., Kumar R., Amisten S., Lundquist I., Salehi A. Activation of G protein-coupled receptor 30 modulates hormone secretion and counteracts cytokine-induced apoptosis in pancreatic islets of female mice. Mol. Cell. Endocrinol 2010, 320(1-2):16-24.
9. Baltgalvis K.A., Greising S.M., Warren G.L., Lowe D.A. Estrogen regulates estrogen receptors and antioxidant gene expression in mouse skeletal muscle. PLoS ONE 2010, 5(4):e10164. PMCID: 2854140.
10. Banks E.A., Brozinick J.T., Yaspelkis B.B., Kang H.Y., Ivy J.L. Muscle glucose transport, GLUT-4 content, and degree of exercise training in obese Zucker rats. Am. J. Physiol 1992, 263(5 Pt 1):E1010-E1015.
11. Baquie M., St-Onge L., Kerr-Conte J., Cobo-Vuilleumier N., Lorenzo P.I., Jimenez Moreno C.M., et al. The liver receptor homolog-1 (LRH-1) is expressed in human islets and protects {beta}-cells against stress-induced apoptosis. Hum. Mol. Genet 2011, 20(14):2823-2833.
12. Barros R.P., Gustafsson J.A. Estrogen receptors and the metabolic network. Cell Metab 2011, 14(3):289-299.
13. Barros R.P., Morani A., Moriscot A., Machado U.F. Insulin resistance of pregnancy involves estrogen-induced repression of muscle GLUT4. Mol. Cell. Endocrinol 2008, 295(1-2):24-31.
14. Barros R.P., Gabbi C., Morani A., Warner M., Gustafsson J.A. Participation of ERalpha and ERbeta in glucose homeostasis in skeletal muscle and white adipose tissue. Am. J. Physiol. Endocrinol. Metab 2009, 297(1):E124-E133.
15. Barros R.P.A., Machado U.F., Warner M., Gustafsson J.-Å. Muscle GLUT4 regulation by estrogen receptors ERβ and ERα. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(5):1605-1608.
16. Baskin D.G., Schwartz M.W., Seeley R.J., Woods S.C., Porte D.J., Breininger J.F., et al. Leptin receptor long form splice variant protein expression in neuron cell bodies of the brain and colocalization with neuropeptide Y mRNA in the arcuate nucleus. J. Histochem. Cytochem 1999, 47:353-362.
17. Befroy D.E., Petersen K.F., Dufour S., Mason G.F., de Graaf R.A., Rothman D.L., et al. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes 2007, 56(5):1376-1381. PMCID: 2995532.
18. Bennett P.A., Lindell K., Wilson C., Carlsson L.M., Carlsson B., Robinson I.C. Cyclical variations in the abundance of leptin receptors, but not in circulating leptin, correlate with NPY expression during the oestrous cycle. Neuroendocrinology 1999, 69(6):417-423.
19. Bjorntorp P. Abdominal fat distribution and disease: an overview of epidemiological data. Ann. Med 1992, 24(1):15-18.
20. Bjorntorp P. Abdominal fat distribution and the metabolic syndrome. J. Cardiovasc. Pharmacol 1992, 20(Suppl. 8):S26-S28.
21. Bjorntorp P. Hormonal effects on fat distribution and its relationship to health risk factors. Acta Paediatr. Suppl 1992, 383:59-60. discussion 1.
22. Bjorntorp P. The android woman - a risky condition. J. Intern. Med 1996, 239(2):105-110.
23. Blaustein J.D., Wade G.N. Ovarian influences on the meal patterns of female rats. Physiol. Behav 1976, 17(2):201-208.
24. Bohler H.C., Tracer H., Merriam G.R., Petersen S.L. Changes in proopiomelanocortin messenger ribonucleic acid levels in the rostral periarcuate region of the female rat during the estrous cycle. Endocrinology 1991, 128(3):1265-1269.
25. Boland R., Vasconsuelo A., Milanesi L., Ronda A.C., de Boland A.R. 17beta-Estradiol signaling in skeletal muscle cells and its relationship to apoptosis. Steroids 2008, 73(9-10):859-863.
26. Bonavera J.J., Dube M.G., Kalra P.S., Kalra S.P. Anorectic effects of estrogen may be mediated by decreased neuropeptide-Y release in the hypothalamic paraventricular nucleus. Endocrinology 1994, 134(6):2367-2370.
27. Borras C., Sastre J., Garcia-Sala D., Lloret A., Pallardo F.V., Vina J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic. Biol. Med 2003, 34(5):546-552.
28. Bouchard C., Despres J.P., Mauriege P. Genetic and nongenetic determinants of regional fat distribution. Endocr. Rev 1993, 14(1):72-93.
29. Brozinick J.T., Etgen G.J., Yaspelkis B.B., Kang H.Y., Ivy J.L. Effects of exercise training on muscle GLUT-4 protein content and translocation in obese Zucker rats. Am. J. Physiol 1993, 265(3 Pt 1):E419-E427.
30. Brozinick J.T., Etgen G.J., Yaspelkis B.B., Ivy J.L. Glucose uptake and GLUT-4 protein distribution in skeletal muscle of the obese Zucker rat. Am. J. Physiol 1994, 267(1 Pt 2):R236-R243.
31. Bryzgalova G., Gao H., Ahren B., Zierath J.R., Galuska D., Steiler T.L., et al. Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 2006, 49(3):588-597.
32. Bryzgalova G., Lundholm L., Portwood N., Gustafsson J.A., Khan A., Efendic S., et al. Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. Am. J. Physiol. Endocrinol. Metab 2008, 295(4):E904-E912.
33. Calippe B., Douin-Echinard V., Delpy L., Laffargue M., Lelu K., Krust A., et al. 17Beta-estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor alpha signaling in macrophages in vivo. J. Immunol 2010, 185(2):1169-1176.
34. Campbell S.E., Febbraio M.A. Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake. Am. J. Physiol. Endocrinol. Metab 2002, 282(5):E1139-E1146.
35. Campbell S.E., Mehan K.A., Tunstall R.J., Febbraio M.A., Cameron-Smith D. 17beta-Estradiol upregulates the expression of peroxisome proliferator-activated receptor alpha and lipid oxidative genes in skeletal muscle. J. Mol. Endocrinol 2003, 31(1):37-45.
36. Carr M.C. The emergence of the metabolic syndrome with menopause. J. Clin. Endocrinol. Metab 2003, 88(6):2404-2411.
37. Casazza K., Page G.P., Fernandez J.R. The association between the rs2234693 and rs9340799 estrogen receptor alpha gene polymorphisms and risk factors for cardiovascular disease: a review. Biol. Res. Nurs 2010, 12(1):84-97.
38. Charn T.H., Liu E.T., Chang E.C., Lee Y.K., Katzenellenbogen J.A., Katzenellenbogen B.S. Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection. Mol. Endocrinol 2010, 24(1):47-59. PMCID: 2802902.
39. Chavez M., van Dijk G., Arkies B.J., Woods S.C. Third ventricular insulin infusion attenuates NPY-induced feeding at the level of the paraventricular nucleus. Obes. Res 1995, 3:335s.
40. Chawla A., Nguyen K.D., Goh Y.P. Macrophage-mediated inflammation in metabolic disease. Nat. Rev. Immunol 2011, 11(11):738-749.
41. Chen Z., Bassford T., Green S.B., Cauley J.A., Jackson R.D., LaCroix A.Z., et al. Postmenopausal hormone therapy and body composition - a substudy of the estrogen plus progestin trial of the Women's Health Initiative. Am. J. Clin. Nutr 2005, 82(3):651-656.
42. Choe S.S., Choi A.H., Lee J.W., Kim K.H., Chung J.J., Park J., et al. Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic beta-cells. Diabetes 2007, 56(6):1534-1543.
43. Choi C.S., Fillmore J.J., Kim J.K., Liu Z.X., Kim S., Collier E.F., et al. Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance. J. Clin. Invest 2007, 117(7):1995-2003. PMCID: 1888566.
44. Chung S.S., Kim M., Youn B.S., Lee N.S., Park J.W., Lee I.K., et al. Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cells. Mol. Cell. Biol 2009, 29(1):20-30. PMCID: 2612482.
45. Clegg D.J., Benoit S.C., Barrera J.G., Woods S.C. Estrogen mediates body fat distribution and brain sensitivity to adiposity signals. Diabetes 2003, 52(Suppl. 1).
46. Clegg D.J., Riedy C.A., Smith K.A., Benoit S.C., Woods S.C. Differential sensitivity to central leptin and insulin in male and female rats. Diabetes 2003, 52(3):682-687.
47. Clegg D.J., Brown L.M., Woods S.C., Benoit S.C. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes 2006, 55(4):978-987.
48. Cone R.D., Cowley M.A., Butler A.A., Fan W., Marks D.L., Low M.J. The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int. J. Obes. Relat. Metab. Disord 2001, 25(Suppl. 5):S63-S67.
49. Contreras J.L., Smyth C.A., Bilbao G., Young C.J., Thompson J.A., Eckhoff D.E. 17beta-Estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality. Transplantation 2002, 74(9):1252-1259.
50. Cortright R.N., Koves T.R. Sex differences in substrate metabolism and energy homeostasis. Can. J. Appl. Physiol 2000, 25(4):288-311.
51. Danguir J., Nicolaidis S. Cortical activity and sleep in the rat lateral hypothalamic syndrome. Brain Res 1980, 185(2):305-321.
52. DeFronzo R.A., Bonadonna R.C., Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992, 15(3):318-368.
53. Dela F., Ploug T., Handberg A., Petersen L.N., Larsen J.J., Mikines K.J., et al. Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes 1994, 43(7):862-865.
54. Della Torre S., Rando G., Meda C., Stell A., Chambon P., Krust A., et al. Amino acid-dependent activation of liver estrogen receptor alpha integrates metabolic and reproductive functions via IGF-1. Cell Metab 2011, 13(2):205-214.
55. Deng H.W., Li J., Li J.L., Dowd R., Davies K.M., Johnson M., et al. Association of estrogen receptor-alpha genotypes with body mass index in normal healthy postmenopausal Caucasian women. J. Clin. Endocrinol. Metab 2000, 85(8):2748-2751.
56. D'Eon T.M., Rogers N.H., Stancheva Z.S., Greenberg A.S. Estradiol and the estradiol metabolite, 2-hydroxyestradiol, activate AMP-activated protein kinase in C2C12 myotubes. Obesity (Silver Spring) 2008, 16(6):1284-1288.
57. Dhillon S.S., Belsham D.D. Estrogen inhibits NPY secretion through membrane-associated estrogen receptor (ER)-alpha in clonal, immortalized hypothalamic neurons. Int. J. Obes. (Lond) 2011, 35:198-207.
58. Diano S., Kalra S.P., Sakamoto H., Horvath T.L. Leptin receptors in estrogen receptor-containing neurons of the female rat hypothalamus. Brain Res 1998, 812(1-2):256-259.
59. Dieli-Conwright C.M., Spektor T.M., Rice J.C., Sattler F.R., Schroeder E.T. Hormone therapy attenuates exercise-induced skeletal muscle damage in postmenopausal women. J. Appl. Physiol 2009, 107(3):853-858.
60. Ding E.L., Song Y., Manson J.E., Rifai N., Buring J.E., Liu S. Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study. Diabetologia 2007, 50(10):2076-2084.
61. Djouadi F., Weinheimer C.J., Saffitz J.E., Pitchford C., Bastin J., Gonzalez F.J., et al. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor alpha-deficient mice. J. Clin. Invest 1998, 102(6):1083-1091. PMCID: 509091.
62. Donahue R.P., Abbott R.D. Central obesity and coronary heart disease in men. Lancet 1987, 2(8569):1215.
63. Donahue R.P., Orchard T.J., Becker D.J., Kuller L.H., Drash A.L. Sex differences in the coronary heart disease risk profile: a possible role for insulin. The Beaver County Study. Am. J. Epidemiol 1987, 125(4):650-657.
64. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol 2011, 11(2):98-107.
65. Douin-Echinard V., Calippe B., Billon-Gales A., Fontaine C., Lenfant F., Tremollieres F., et al. Estradiol administration controls eosinophilia through estrogen receptor-alpha activation during acute peritoneal inflammation. J. Leukoc. Biol 2011, 90(1):145-154.
66. Drew B.G., Hamidi H., Zhou Z., Villanueva C.J., Krum S.A., Calkin A.C., et al. Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression. J. Biol. Chem 2015, 290(9):5566-5581.
67. Drewett R.F. Sexual behaviour and sexual motivation in the female rat. Nature 1973, 242(5398):476-477.
68. Dulos J., Vijn P., van Doorn C., Hofstra C.L., Veening-Griffioen D., de Graaf J., et al. Suppression of the inflammatory response in experimental arthritis is mediated via estrogen receptor alpha but not estrogen receptor beta. Arthritis Res. Ther 2010, 12(3):R101. PMCID: 2911889.
69. Elbers J.M., Asscheman H., Seidell J.C., Gooren L.J. Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals. Am. J. Physiol 1999, 276(2 Pt 1):E317-E325.
70. Elbers J.M., de Roo G.W., Popp-Snijders C., Nicolaas-Merkus A., Westerveen E., Joenje B.W., et al. Effects of administration of 17beta-oestradiol on serum leptin levels in healthy postmenopausal women. Clin. Endocrinol. (Oxf) 1999, 51(4):449-454.
71. Elias C.F., Aschkenasi C., Lee C., Kelly J., Ahima R.S., Bjorbaek C., et al. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 1999, 23(4):775-786.
72. Elias C.F., Kelly J.F., Lee C.E., Ahima R.S., Drucker D.J., Saper C.B., et al. Chemical characterization of leptin-activated neurons in the rat brain. J. Comp. Neurol 2000, 423(2):261-281.
73. Elmquist J.K., Maratos-Flier E., Saper C.B., Flier J.S. Unraveling the central nervous system pathways underlying responses to leptin. Nat. Neurosci 1998, 1:445-450.
74. Elmquist J.K., Ahima R.S., Elias C.F., Flier J.S., Saper C.B. Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:741-746.
75. Elmquist J.K., Bjorbaek C., Ahima R.S., Flier J.S., Saper C.B. Distributions of leptin receptor mRNA isoforms in the rat brain. J. Comp. Neurol 1998, 395(4):535-547.
76. Elmquist J.K., Elias C.F., Saper C.B. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 1999, 22:221-232.
77. Enns D.L., Tiidus P.M. Estrogen influences satellite cell activation and proliferation following downhill running in rats. J. Appl. Physiol 2008, 104(2):347-353.
78. Enns D.L., Iqbal S., Tiidus P.M. Oestrogen receptors mediate oestrogen-induced increases in post-exercise rat skeletal muscle satellite cells. Acta Physiol. (Oxf.) 2008, 194(1):81-93.
79. Enzi G., Gasparo M., Biondetti P.R., Fiore D., Semisa M., Zurlo F. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am. J. Clin. Nutr 1986, 44(6):739-746.
80. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol 2000, 14(10):1649-1660.
81. Finan B., Yang B., Gelfanov V., Ottaway N., Pfluger P., Perez-Tilve D., et al. Estrogen conjugates of GLP-1 demonstrate enhanced efficacy in diet-induced obese mice 2011, Keystone Symposia Type 2 Diabetes, Insulin Resistance and Metabolic Dysfunction. January 12-17.
82. Finan B., Yang B., Ottaway N., Stemmer K., Muller T.D., Yi C.X., et al. Targeted estrogen delivery reverses the metabolic syndrome. Nat. Med 2012, 18(12):1847-1856.
83. Flegal K.M., Carroll M.D., Ogden C.L., Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002, 288(14):1723-1727.
84. Foryst-Ludwig A., Clemenz M., Hohmann S., Hartge M., Sprang C., Frost N., et al. Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma. PLoS Genet 2008, 4(6):e1000108. PMCID: 2432036.
85. Freedman D.S., Khan L.K., Serdula M.K., Galuska D.A., Dietz W.H. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 2002, 288(14):1758-1761.
86. Frias J.P., Macaraeg G.B., Ofrecio J., Yu J.G., Olefsky J.M., Kruszynska Y.T. Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women. Diabetes 2001, 50(6):1344-1350.
87. Fu M.H., Maher A.C., Hamadeh M.J., Ye C., Tarnopolsky M.A. Exercise, sex, menstrual cycle phase, and 17beta-estradiol influence metabolism-related genes in human skeletal muscle. Physiol. Genomics 2009, 40(1):34-47.
88. Furtado L.M., Somwar R., Sweeney G., Niu W., Klip A. Activation of the glucose transporter GLUT4 by insulin. Biochem. Cell Biol 2002, 80(5):569-578.
89. Gabriely I., Ma X.H., Yang X.M., Atzmon G., Rajala M.W., Berg A.H., et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?. Diabetes 2002, 51(10):2951-2958.
90. Galluzzo P., Rastelli C., Bulzomi P., Acconcia F., Pallottini V., Marino M. 17beta-Estradiol regulates the first steps of skeletal muscle cell differentiation via ER-alpha-mediated signals. Am. J. Physiol. Cell Physiol 2009, 297(5):C1249-C1262.
91. Gambacciani M., Ciaponi M., Cappagli B., Piaggesi L., De Simone L., Orlandi R., et al. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J. Clin. Endocrinol. Metab 1997, 82(2):414-417.
92. Gan Z., Burkart-Hartman E.M., Han D.H., Finck B., Leone T.C., Smith E.Y., et al. The nuclear receptor PPARbeta/delta programs muscle glucose metabolism in cooperation with AMPK and MEF2. Genes Dev 2011, 25(24):2619-2630.
93. Gao H., Bryzgalova G., Hedman E., Khan A., Efendic S., Gustafsson J.A., et al. Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Mol. Endocrinol 2006, 20(6):1287-1299.
94. Gao Q., Mezei G., Nie Y., Rao Y., Choi C.S., Bechmann I., et al. Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nat. Med 2007, 13(1):89-94.
95. Garvey W.T., Maianu L., Hancock J.A., Golichowski A.M., Baron A. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes 1992, 41(4):465-475.
96. Garvey W.T., Maianu L., Zhu J.H., Brechtel-Hook G., Wallace P., Baron A.D. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J. Clin. Invest 1998, 101(11):2377-2386. PMCID: 508827.
97. Geary N., Asarian L., Korach K.S., Pfaff D.W., Ogawa S. Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-alpha null mice. Endocrinology 2001, 142(11):4751-4757.
98. Gold S.M., Sasidhar M.V., Morales L.B., Du S., Sicotte N.L., Tiwari-Woodruff S.K., et al. Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha). Lab. Invest 2009, 89(10):1076-1083. PMCID: 2753699.
99. Gomez-Perez Y., Amengual-Cladera E., Catala-Niell A., Thomas-Moya E., Gianotti M., Proenza A.M., et al. Gender dimorphism in high-fat-diet-induced insulin resistance in skeletal muscle of aged rats. Cell. Physiol. Biochem 2008, 22(5-6):539-548.
100. Gong H., Xie J., Zhang N., Yao L., Zhang Y. MEF2A binding to the Glut4 promoter occurs via an AMPKalpha2-dependent mechanism. Med. Sci. Sports Exerc 2011, 43(8):1441-1450.
101. Gorres B.K., Bomhoff G.L., Morris J.K., Geiger P.C. In vivo stimulation of oestrogen receptor alpha increases insulin-stimulated skeletal muscle glucose uptake. J. Physiol 2011, 589(Pt 8):2041-2054. PMCID: 3090602.
102. Guercio G., Di Palma M.I., Pepe C., Saraco N.I., Prieto M., Saure C., et al. Metformin, estrogen replacement therapy and gonadotropin inhibition fail to improve insulin sensitivity in a girl with aromatase deficiency. Horm. Res 2009, 72(6):370-376.
103. Haarbo J., Hansen B.F., Christiansen C. Hormone replacement therapy prevents coronary artery disease in ovariectomized cholesterol-fed rabbits. APMIS 1991, 99(8):721-727.
104. Haarbo J., Marslew U., Gotfredsen A., Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991, 40(12):1323-1326.
105. Hamadeh M.J., Devries M.C., Tarnopolsky M.A. Estrogen supplementation reduces whole body leucine and carbohydrate oxidation and increases lipid oxidation in men during endurance exercise. J. Clin. Endocrinol. Metab 2005, 90(6):3592-3599.
106. Hammes S.R., Levin E.R. Extranuclear steroid receptors: nature and actions. Endocr. Rev 2007, 28(7):726-741.
107. Hansen P.A., McCarthy T.J., Pasia E.N., Spina R.J., Gulve E.A. Effects of ovariectomy and exercise training on muscle GLUT-4 content and glucose metabolism in rats. J. Appl. Physiol 1996, 80(5):1605-1611.
108. Hardie D.G. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev 2011, 25(18):1895-1908. PMCID: 3185962.
109. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(23):12729-12734. PMCID: 18832.
110. Hepworth M.R., Hardman M.J., Grencis R.K. The role of sex hormones in the development of Th2 immunity in a gender-biased model of Trichuris muris infection. Eur. J. Immunol 2010, 40(2):406-416.
111. Herzog H. Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models. Eur. J. Pharmacol 2003, 480(1-3):21-29.
112. Hevener A., Reichart D., Janez A., Olefsky J. Female rats do not exhibit free fatty acid-induced insulin resistance. Diabetes 2002, 51(6):1907-1912.
113. Hevener A.L., Olefsky J.M., Reichart D., Nguyen M.T., Bandyopadyhay G., Leung H.Y., et al. Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J. Clin. Invest 2007, 117(6):1658-1669.
114. Hewitt K.N., Pratis K., Jones M.E.E., Simpson E.R. Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology 2004, 145(4):1842-1848.
115. Hill J.W., Urban J.H., Xu M., Levine J.E. Estrogen induces neuropeptide Y (NPY) Y1 receptor gene expression and responsiveness to NPY in gonadotrope-enriched pituitary cell cultures. Endocrinology 2004, 145(5):2283-2290.
116. Hirosawa M., Minata M., Harada K.H., Hitomi T., Krust A., Koizumi A. Ablation of estrogen receptor alpha (ERalpha) prevents upregulation of POMC by leptin and insulin. Biochem. Biophys. Res. Commun 2008, 371(2):320-323.
117. Hoeg L., Roepstorff C., Thiele M., Richter E.A., Wojtaszewski J.F., Kiens B. Higher intramuscular triacylglycerol in women does not impair insulin sensitivity and proximal insulin signaling. J. Appl. Physiol 2009, 107(3):824-831.
118. Hoeg L.D., Sjoberg K.A., Jeppesen J., Jensen T.E., Frosig C., Birk J.B., et al. Lipid-induced insulin resistance affects women less than men and is not accompanied by inflammation or impaired proximal insulin signaling. Diabetes 2011, 60(1):64-73. PMCID: 3012198.
119. Holland W.L., Brozinick J.T., Wang L.P., Hawkins E.D., Sargent K.M., Liu Y., et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 2007, 5(3):167-179.
120. Holland W.L., Knotts T.A., Chavez J.A., Wang L.P., Hoehn K.L., Summers S.A. Lipid mediators of insulin resistance. Nutr. Rev 2007, 65(6 Pt 2):S39-S46.
121. Hong J., Stubbins R.E., Smith R.R., Harvey A.E., Nunez N.P. Differential susceptibility to obesity between male, female and ovariectomized female mice. Nutr. J. 2009, 8:11. PMCID: 2650703.
122. Hotamisligil G.S. Inflammation and endoplasmic reticulum stress in obesity and diabetes. Int. J. Obes. (Lond) 2008, 32(Suppl. 7):S52-S54. PMCID: 2885768.
123. Itani S.I., Ruderman N.B., Schmieder F., Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002, 51(7):2005-2011.
124. Jones M.E., Thorburn A.W., Britt K.L., Hewitt K.N., Wreford N.G., Proietto J., et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(23):12735-12740. PMCID: 18833.
125. Jones M.E., McInnes K.J., Boon W.C., Simpson E.R. Estrogen and adiposity - utilizing models of aromatase deficiency to explore the relationship. J. Steroid Biochem. Mol. Biol 2007, 106(1-5):3-7.
126. Kalyani R.R., Franco M., Dobs A.S., Ouyang P., Vaidya D., Bertoni A., et al. The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J. Clin. Endocrinol. Metab 2009, 94(11):4127-4135. PMCID: 2775652.
127. Kamanga-Sollo E., White M.E., Hathaway M.R., Weber W.J., Dayton W.R. Effect of estradiol-17beta on protein synthesis and degradation rates in fused bovine satellite cell cultures. Domest. Anim. Endocrinol 2010, 39(1):54-62.
128. Kang L., Zhang X., Xie Y., Tu Y., Wang D., Liu Z., et al. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol. Endocrinol 2010, 24(4):709-721. PMCID: 2852353.
129. Kim J.Y., Jo K.J., Kim O.S., Kim B.J., Kang D.W., Lee K.H., et al. Parenteral 17beta-estradiol decreases fasting blood glucose levels in non-obese mice with short-term ovariectomy. Life Sci 2010, 87(11-12):358-366.
130. Kim M., Neinast M.D., Frank A.P., Sun K., Park J., Zehr J.A., et al. ERα upregulates Phd3 to ameliorate HIF-1 induced fibrosis and inflammation in adipose tissue. Mol. Metab 2014, 3(6):642-651.
131. Klein P.W., Easterbrook J.D., Lalime E.N., Klein S.L. Estrogen and progesterone affect responses to malaria infection in female C57BL/6 mice. Gend. Med 2008, 5(4):423-433.
132. Korner J., Chua S.C., Williams J.A., Leibel R.L., Wardlaw S.L. Regulation of hypothalamic proopiomelanocortin by leptin in lean and obese rats. Neuroendocrinology 1999, 70(6):377-383.
133. Kumar R., Balhuizen A., Amisten S., Lundquist I., Salehi A. Insulinotropic and antidiabetic effects of 17{beta}-estradiol and the GPR30 agonist G-1 on human pancreatic islets. Endocrinology 2011, 152(7):2568-2579.
134. Lapidus L., Bengtsson C., Larsson B., Pennert K., Rybo E., Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br. Med. J. (Clin. Res. Ed) 1984, 289:1257-1261.
135. Le May C., Chu K., Hu M., Ortega C.S., Simpson E.R., Korach K.S., et al. Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(24):9232-9237. PMCID: 1482595.
136. Lee Y.R., Park J., Yu H.N., Kim J.S., Youn H.J., Jung S.H. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells. Biochem. Biophys. Res. Commun 2005, 336(4):1221-1226.
137. Leger B., Derave W., De Bock K., Hespel P., Russell A.P. Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation. Rejuvenation Res 2008, 11(1):163-175B.
138. Lemoine S., Granier P., Tiffoche C., Berthon P.M., Thieulant M.L., Carre F., et al. Effect of endurance training on oestrogen receptor alpha expression in different rat skeletal muscle type. Acta Physiol. Scand 2002, 175(3):211-217.
139. Lemoine S., Granier P., Tiffoche C., Berthon P.M., Rannou-Bekono F., Thieulant M.L., et al. Effect of endurance training on oestrogen receptor alpha transcripts in rat skeletal muscle. Acta Physiol. Scand 2002, 174(3):283-289.
140. Levin B.E. Arcuate NPY neurons and energy homeostasis in diet-induced obese and resistant rats. Am. J. Physiol 1999, 276(2 Pt 2):R382-R387.
141. Lezama-Davila C.M., Isaac-Marquez A.P., Barbi J., Cummings H.E., Lu B., Satoskar A.R. Role of phosphatidylinositol-3-kinase-gamma (PI3Kgamma)-mediated pathway in 17beta-estradiol-induced killing of L. mexicana in macrophages from C57BL/6 mice. Immunol. Cell Biol 2008, 86(6):539-543.
142. Liang Y.Q., Akishita M., Kim S., Ako J., Hashimoto M., Iijima K., et al. Estrogen receptor beta is involved in the anorectic action of estrogen. Int. J. Obes. Relat. Metab. Disord 2002, 26(8):1103-1109.
143. Lindell K., Bennett P.A., Itoh Y., Robinson I.C., Carlsson L.M., Carlsson B. Leptin receptor 5' untranslated regions in the rat: relative abundance, genomic organization and relation to putative response elements. Mol. Cell. Endocrinol 2001, 172(1-2):37-45.
144. Liu S., Mauvais-Jarvis F. Rapid, nongenomic estrogen actions protect pancreatic islet survival. Islets 2009, 1(3):273-275. PMCID: 2903892.
145. Liu S., Mauvais-Jarvis F. Minireview: estrogenic protection of beta-cell failure in metabolic diseases. Endocrinology 2010, 151(3):859-864. PMCID: 2840685.
146. Liu S., Le May C., Wong W.P., Ward R.D., Clegg D.J., Marcelli M., et al. Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes 2009, 58(10):2292-2302. PMCID: 2750222.
147. Liu S., Kilic G., Mauvais-Jarvis F. Estrogens improve angiogenesis during pancreatic islet transplantation (Abstract) 2010, Keystone Symposia on islet Biology Whistler, BC, Canada.
148. Louis-Sylvestre J. Neuroendocrinology of hyperphagias and obesities. Reprod. Nutr. Dev 1980, 20(5B):1545-1562.
149. Lundholm L., Bryzgalova G., Gao H., Portwood N., Falt S., Berndt K.D., et al. The estrogen receptor {alpha}-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice; potential molecular mechanisms. J. Endocrinol 2008, 199(2):275-286.
150. Maffei L., Murata Y., Rochira V., Tubert G., Aranda C., Vazquez M., et al. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J. Clin. Endocrinol. Metab 2004, 89(1):61-70.
151. Maffei L., Rochira V., Zirilli L., Antunez P., Aranda C., Fabre B., et al. A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome. Clin. Endocrinol. (Oxf) 2007, 67(2):218-224.
152. Maher A.C., Akhtar M., Vockley J., Tarnopolsky M.A. Women have higher protein content of beta-oxidation enzymes in skeletal muscle than men. PLoS ONE 2010, 5(8):e12025. PMCID: 2917369.
153. Maher A.C., Akhtar M., Tarnopolsky M.A. Men supplemented with 17beta-estradiol have increased beta-oxidation capacity in skeletal muscle. Physiol. Genomics 2010, 42(3):342-347.
154. Mannella P., Brinton R.D. Estrogen receptor protein interaction with phosphatidylinositol 3-kinase leads to activation of phosphorylated Akt and extracellular signal-regulated kinase 1/2 in the same population of cortical neurons: a unified mechanism of estrogen action. J. Neurosci 2006, 26(37):9439-9447.
155. McLoughlin T.J., Smith S.M., DeLong A.D., Wang H., Unterman T.G., Esser K.A. FoxO1 induces apoptosis in skeletal myotubes in a DNA-binding-dependent manner. Am. J. Physiol. Cell Physiol 2009, 297(3):C548-C555. PMCID: 2740395.
156. Merchenthaler I., Lane M.V., Numan S., Dellovade T.L. Distribution of estrogen receptor alpha and beta in the mouse central nervous system: in vivo autoradiographic and immunocytochemical analyses. J. Comp. Neurol 2004, 473(2):270-291.
157. Messier V., Rabasa-Lhoret R., Barbat-Artigas S., Elisha B., Karelis A.D., Aubertin-Leheudre M. Menopause and sarcopenia: a potential role for sex hormones. Maturitas 2011, 68(4):331-336.
158. Mihaylova M.M., Shaw R.J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell Biol 2011, 13(9):1016-1023. PMCID: 3249400.
159. Milam K.M., Stern J.S., Storlien L.H., Keesey R.E. Effect of lateral hypothalamic lesions on regulation of body weight and adiposity in rats. Am. J. Physiol 1980, 239(3):R337-R343.
160. Minami T., Oomura Y., Nabekura J., Fukuda A. 17 beta-estradiol depolarization of hypothalamic neurons is mediated by cyclic AMP. Brain Res 1990, 519(1-2):301-307.
161. Miranda P.J., DeFronzo R.A., Califf R.M., Guyton J.R. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am. Heart J. 2005, 149(1):33-45.
162. Mizutani T., Nishikawa Y., Adachi H., Enomoto T., Ikegami H., Kurachi H., et al. Identification of estrogen receptor in human adipose tissue and adipocytes. J. Clin. Endocrinol. Metab 1994, 78(4):950-954.
163. Mora S., Pessin J.E. The MEF2A isoform is required for striated muscle-specific expression of the insulin-responsive GLUT4 glucose transporter. J. Biol. Chem 2000, 275(21):16323-16328.
164. Moreno H., Serrano A.L., Santalucia T., Guma A., Canto C., Brand N.J., et al. Differential regulation of the muscle-specific GLUT4 enhancer in regenerating and adult skeletal muscle. J. Biol. Chem 2003, 278(42):40557-40564.
165. Morino K., Petersen K.F., Dufour S., Befroy D., Frattini J., Shatzkes N., et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J. Clin. Invest 2005, 115(12):3587-3593. PMCID: 1280967.
166. Morishima A., Grumbach M.M., Simpson E.R., Fisher C., Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Clin. Endocrinol. Metab 1995, 80(12):3689-3698.
167. Murgia M., Jensen T.E., Cusinato M., Garcia M., Richter E.A., Schiaffino S. Multiple signalling pathways redundantly control glucose transporter GLUT4 gene transcription in skeletal muscle. J. Physiol 2009, 587(17):4319-4327. PMCID: 19596898.
168. Musatov S., Chen W., Pfaff D.W., Mobbs C.V., Yang X.J., Clegg D.J., et al. Silencing of estrogen receptor {alpha} in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc. Natl. Acad. Sci. U.S.A. 2007, 104(7):2501-2506.
169. Myers M.G., Leibel R.L., Seeley R.J., Schwartz M.W. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol. Metab 2010, 21(11):643-651. PMCID: 2967652.
170. Naaz A., Zakroczymski M., Heine P., Taylor J., Saunders P., Lubahn D., et al. Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ERalpha): a potential role for estrogen receptor beta (ERbeta). Horm. Metab. Res 2002, 34(11-12):758-763.
171. Nadal A., Alonso-Magdalena P., Soriano S., Quesada I., Ropero A.B. The pancreatic beta-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes. Mol. Cell. Endocrinol 2009, 304(1-2):63-68.
172. Nilsson M., Dahlman I., Ryden M., Nordstrom E.A., Gustafsson J.A., Arner P., et al. Oestrogen receptor alpha gene expression levels are reduced in obese compared to normal weight females. Int. J. Obes. (Lond) 2007, 31(6):900-907.
173. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., et al. Mechanisms of estrogen action. Physiol. Rev 2001, 81(4):1535-1565.
174. Niu W., Huang C., Nawaz Z., Levy M., Somwar R., Li D., et al. Maturation of the regulation of GLUT4 activity by p38 MAPK during L6 cell myogenesis. J. Biol. Chem 2003, 278(20):17953-17962.
175. Noh E.M., Lee Y.R., Chay K.O., Chung E.Y., Jung S.H., Kim J.S., et al. Estrogen receptor alpha induces down-regulation of PTEN through PI3-kinase activation in breast cancer cells. Mol. Med. Rep 2011, 4(2):215-219.
176. North American Menopause Society The 2012 hormone therapy position statement of: the North American Menopause Society. Menopause 2012, 19(3):257-271.
177. Ogawa S., Chan J., Chester A.E., Gustafsson J.A., Korach K.S., Pfaff D.W. Survival of reproductive behaviors in estrogen receptor beta gene-deficient (betaERKO) male and female mice. Proc. Natl. Acad. Sci. U.S.A. 1999, 96(22):12887-12892.
178. Ohlson L.O., Larsson B., Svardsudd K., Welin L., Eriksson H., Wilhelmsen L., et al. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985, 34(10):1055-1058.
179. Ohlsson C., Hellberg N., Parini P., Vidal O., Bohlooly-Y M., Rudling M., et al. Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem. Biophys. Res. Commun 2000, 278(3):640-645.
180. Okura T., Koda M., Ando F., Niino N., Ohta S., Shimokata H. Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution. Int. J. Obes. Relat. Metab. Disord 2003, 27(9):1020-1027.
181. Okura T., Koda M., Ando F., Niino N., Shimokata H. Relationships of resting energy expenditure with body fat distribution and abdominal fatness in Japanese population. J. Physiol. Anthropol. Appl. Human Sci 2003, 22(1):47-52.
182. Okura T., Koda M., Ando F., Niino N., Tanaka M., Shimokata H. Association of the mitochondrial DNA 15497G/A polymorphism with obesity in a middle-aged and elderly Japanese population. Hum. Genet 2003, 113(5):432-436.
183. Olefsky J.M., Glass C.K. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol 2010, 72:219-246.
184. Olofsson L.E., Pierce A.A., Xu A.W. Functional requirement of AgRP and NPY neurons in ovarian cycle-dependent regulation of food intake. Proc. Natl. Acad. Sci. U.S.A. 2009, 106(37):15932-15937.
185. O'Malley B.W. Mechanisms of action of steroid hormones. N. Engl. J. Med 1971, 284(7):370-377.
186. Ordonez P., Moreno M., Alonso A., Llaneza P., Diaz F., Gonzalez C. 17beta-Estradiol and/or progesterone protect from insulin resistance in STZ-induced diabetic rats. J. Steroid Biochem. Mol. Biol 2008, 111(3-5):287-294.
187. Oshel K.M., Knight J.B., Cao K.T., Thai M.V., Olson A.L. Identification of a 30-base pair regulatory element and novel DNA binding protein that regulates the human GLUT4 promoter in transgenic mice. J. Biol. Chem 2000, 275(31):23666-23673.
188. Osterlund M., Kuiper G.G., Gustafsson J.A., Hurd Y.L. Differential distribution and regulation of estrogen receptor-alpha and -beta mRNA within the female rat brain. Brain Res. Mol. Brain Res 1998, 54(1):175-180.
189. Park Y.W., Zhu S., Palaniappan L., Heshka S., Carnethon M.R., Heymsfield S.B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med 2003, 163(4):427-436.
190. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. U.S.A. 2003, 100(14):8466-8471. PMCID: 166252.
191. Petersen K.F., Dufour S., Befroy D., Garcia R., Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med 2004, 350(7):664-671. PMCID: 2995502.
192. Pfeilschifter J., Koditz R., Pfohl M., Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr. Rev 2002, 23(1):90-119.
193. Polidori C., Geary N. Estradiol treatment fails to affect the feeding responses to melanocortin-3/4 receptor agonism or antagonism in ovariectomized rats. Peptides 2002, 23(9):1697-1700.
194. Price T.M., O'Brien S.N. Determination of estrogen receptor messenger ribonucleic acid (mRNA) and cytochrome P450 aromatase mRNA levels in adipocytes and adipose stromal cells by competitive polymerase chain reaction amplification. J. Clin. Endocrinol. Metab 1993, 77(4):1041-1045.
195. Riant E., Waget A., Cogo H., Arnal J.F., Burcelin R., Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology 2009, 150(5):2109-2117.
196. Ribas V., Nguyen M.T., Henstridge D.C., Nguyen A.K., Beaven S.W., Watt M.J., et al. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am. J. Physiol. Endocrinol. Metab 2009, 298:E304-E319. PMCID: 2822483.
197. Ribas V., Nguyen M.T., Henstridge D.C., Nguyen A.K., Beaven S.W., Watt M.J., et al. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am. J. Physiol. Endocrinol. Metab 2010, 298(2):E304-E319. PMCID: 2822483.
198. Ribas V., Drew B.G., Soleymani T., Daraei P., Hevener A. Skeletal muscle specific ER alpha deletion is causal for the metabolic syndrome. Endocr. Rev 2010, 31(3):S5.
199. Ribas V., Drew B.G., Le J.A., Soleymani T., Daraei P., Sitz D., et al. Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(39):16457-16462. PMCID: 3182726.
200. Rochira V., Madeo B., Zirilli L., Caffagni G., Maffei L., Carani C. Oestradiol replacement treatment and glucose homeostasis in two men with congenital aromatase deficiency: evidence for a role of oestradiol and sex steroids imbalance on insulin sensitivity in men. Diabet. Med 2007, 24(12):1491-1495.
201. Rodnick K.J., Holloszy J.O., Mondon C.E., James D.E. Effects of exercise training on insulin-regulatable glucose-transporter protein levels in rat skeletal muscle. Diabetes 1990, 39(11):1425-1429.
202. Roesch D.M. Effects of selective estrogen receptor agonists on food intake and body weight gain in rats. Physiol. Behav 2006, 87(1):39-44.
203. Rogers N.H., Perfield J.W., Strissel K.J., Obin M.S., Greenberg A.S. Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology 2009, 150(5):2161-2168.
204. Rogers N.H., Witczak C.A., Hirshman M.F., Goodyear L.J., Greenberg A.S. Estradiol stimulates Akt, AMP-activated protein kinase (AMPK) and TBC1D1/4, but not glucose uptake in rat soleus. Biochem. Biophys. Res. Commun 2009, 382(4):646-650. PMCID: 2692044.
205. Ronda A.C., Buitrago C., Boland R. Role of estrogen receptors, PKC and Src in ERK2 and p38 MAPK signaling triggered by 17beta-estradiol in skeletal muscle cells. J. Steroid Biochem. Mol. Biol 2010, 122(4):287-294.
206. Ronda A.C., Vasconsuelo A., Boland R. Extracellular-regulated kinase and p38 mitogen-activated protein kinases are involved in the antiapoptotic action of 17beta-estradiol in skeletal muscle cells. J. Endocrinol 2010, 206(2):235-246.
207. Safe S., Kim K. Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J. Mol. Endocrinol 2008, 41(5):263-275. PMCID: 2582054.
208. Salehzadeh F., Rune A., Osler M., Al-Khalili L. Testosterone or 17{beta}-estradiol exposure reveals sex-specific effects on glucose and lipid metabolism in human myotubes. J. Endocrinol 2011, 210(2):219-229.
209. Salonia A., Lanzi R., Scavini M., Pontillo M., Gatti E., Petrella G., et al. Sexual function and endocrine profile in fertile women with type 1 diabetes. Diabetes Care 2006, 29(2):312-316.
210. Santollo J., Wiley M.D., Eckel L.A. Acute activation of ER alpha decreases food intake, meal size, and body weight in ovariectomized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol 2007, 293(6):R2194-R2201.
211. Schneider G., Kirschner M.A., Berkowitz R., Ertel N.H. Increased estrogen production in obese men. J. Clin. Endocrinol. Metab 1979, 48(4):633-638.
212. Schwartz M.W., Woods S.C., Porte D.J., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404:661-671.
213. Shang Y., Hu X., DiRenzo J., Lazar M.A., Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000, 103(6):843-852.
214. Sharma G., Prossnitz E.R. Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells. Endocrinology 2011, 152(8):3030-3039. PMCID: 3138237.
215. Shima N., Yamaguchi Y., Yuri K. Distribution of estrogen receptor beta mRNA-containing cells in ovariectomized and estrogen-treated female rat brain. Anat. Sci. Int 2003, 78(2):85-97.
216. Simerly R.B., Chang C., Muramatsu M., Swanson L.W. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol 1990, 294(1):76-95.
217. Simoncini T., Hafezi-Moghadam A., Brazil D.P., Ley K., Chin W.W., Liao J.K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000, 407(6803):538-541. PMCID: 2670482.
218. Simoncini T., Fornari L., Mannella P., Varone G., Caruso A., Liao J.K., et al. Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system. Interaction of estrogen receptor alpha with phosphatidylinositol 3-OH kinase. Steroids 2002, 67(12):935-939.
219. Simonian S.X., Herbison A.E. Differential expression of estrogen receptor alpha and beta immunoreactivity by oxytocin neurons of rat paraventricular nucleus. J. Neuroendocrinol 1997, 9(11):803-806.
220. Sipila S., Taaffe D.R., Cheng S., Puolakka J., Toivanen J., Suominen H. Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin. Sci. (Lond.) 2001, 101(2):147-157.
221. Sites C.K., Toth M.J., Cushman M., L'Hommedieu G.D., Tchernof A., Tracy R.P., et al. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil. Steril 2002, 77(1):128-135.
222. Slamberova R., Hnatczuk O.C., Vathy I. Expression of proopiomelanocortin and proenkephalin mRNA in sexually dimorphic brain regions are altered in adult male and female rats treated prenatally with morphine. J. Pept. Res 2004, 63(5):399-408.
223. Smith E.P., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specker B., et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med 1994, 331(16):1056-1061.
224. Smith G.P. The controls of eating: a shift from nutritional homeostasis to behavioral neuroscience. Nutrition 2000, 16:814-820.
225. Smith J.A., Kohn T.A., Chetty A.K., Ojuka E.O. CaMK activation during exercise is required for histone hyperacetylation and MEF2A binding at the MEF2 site on the Glut4 gene. Am. J. Physiol. Endocrinol. Metab 2008, 295(3):E698-E704.
226. Sorensen M.B., Rosenfalck A.M., Hojgaard L., Ottesen B. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. Obes. Res 2001, 9(10):622-626.
227. Soriano S., Ropero A.B., Alonso-Magdalena P., Ripoll C., Quesada I., Gassner B., et al. Rapid regulation of K(ATP) channel activity by 17{beta}-estradiol in pancreatic {beta}-cells involves the estrogen receptor {beta} and the atrial natriuretic peptide receptor. Mol. Endocrinol 2009, 23(12):1973-1982.
228. Soriano S., Alonso-Magdalena P., Garcia-Arevalo M., Novials A., Muhammed S.J., Salehi A., et al. Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of Langerhans: role of estrogen receptor beta. PLoS ONE 2012, 7(2):e31109. PMCID: 3275611.
229. Sotiriadou S., Kyparos A., Albani M., Arsos G., Clarke M.S., Sidiras G., et al. Soleus muscle force following downhill running in ovariectomized rats treated with estrogen. Appl. Physiol. Nutr. Metab 2006, 31(4):449-459.
230. Spence R.D., Voskuhl R.R. Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Front. Neuroendocrinol 2012, 33(1):105-115.
231. Stitt T.N., Drujan D., Clarke B.A., Panaro F., Timofeyva Y., Kline W.O., et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell 2004, 14(3):395-403.
232. Stubbins R.E., Holcomb V.B., Hong J., Nunez N.P. Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance. Eur. J. Nutr 2012, 51:861-870.
233. Summers S.A. Ceramides in insulin resistance and lipotoxicity. Prog. Lipid Res 2006, 45(1):42-72.
234. Sweeney G., Somwar R., Ramlal T., Volchuk A., Ueyama A., Klip A. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J. Biol. Chem 1999, 274(15):10071-10078.
235. Takeda K., Toda K., Saibara T., Nakagawa M., Saika K., Onishi T., et al. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J. Endocrinol 2003, 176(2):237-246.
236. Tchernof A., Despres J.P., Dupont A., Belanger A., Nadeau A., Prud'homme D., et al. Relation of steroid hormones to glucose tolerance and plasma insulin levels in men. Importance of visceral adipose tissue. Diabetes Care 1995, 18(3):292-299.
237. Teixeira P.J., Going S.B., Houtkooper L.B., Metcalfe L.L., Blew R.M., Flint-Wagner H.G., et al. Resistance training in postmenopausal women with and without hormone therapy. Med. Sci. Sports Exerc 2003, 35(4):555-562.
238. Thomas A., Bunyan K., Tiidus P.M. Oestrogen receptor-alpha activation augments post-exercise myoblast proliferation. Acta Physiol. (Oxf.) 2010, 198(1):81-89.
239. Thorne A., Lonnqvist F., Apelman J., Hellers G., Arner P. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int. J. Obes. Relat. Metab. Disord 2002, 26(2):193-199.
240. Tiano J., Mauvais-Jarvis F. Selective estrogen receptor modulation in pancreatic beta-cells and the prevention of type 2 diabetes. Islets 2012, 4(2):173-176.
241. Tiano J.P., Mauvais-Jarvis F. Importance of oestrogen receptors to preserve functional beta-cell mass in diabetes. Nat. Rev. Endocrinol 2012, 8(6):342-351.
242. Tiano J.P., Mauvais-Jarvis F. Molecular mechanisms of estrogen receptors' suppression of lipogenesis in pancreatic beta-cells. Endocrinology 2012, 153(7):2997-3005. PMCID: 3380304.
243. Tiano J.P., Delghingaro-Augusto V., Le May C., Liu S., Kaw M.K., Khuder S.S., et al. Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents beta cell failure in rodent models of type 2 diabetes. J. Clin. Invest 2011, 121(8):3331-3342. PMCID: 3148728.
244. Tiidus P.M. Estrogen and gender effects on muscle damage, inflammation, and oxidative stress. Can. J. Appl. Physiol 2000, 25(4):274-287.
245. Tiwari-Woodruff S., Voskuhl R.R. Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice. J. Neurol. Sci 2009, 286(1-2):81-85. PMCID: 2760614.
246. Torgan C.E., Brozinick J.T., Banks E.A., Cortez M.Y., Wilcox R.E., Ivy J.L. Exercise training and clenbuterol reduce insulin resistance of obese Zucker rats. Am. J. Physiol 1993, 264(3 Pt 1):E373-E379.
247. Tran T.T., Yamamoto Y., Gesta S., Kahn C.R. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 2008, 7(5):410-420. PMCID: 3204870.
248. Turcotte L.P., Richter E.A., Kiens B. Increased plasma FFA uptake and oxidation during prolonged exercise in trained vs. untrained humans. Am. J. Physiol 1992, 262(6 Pt 1):E791-E799.
249. van Dijk G., Thiele T.E., Donahey J.C.K., Campfield L.A., Smith F.J., Burn P., et al. Central infusion of leptin and GLP-1 (7-36) amide differentially stimulate c-Fos-like immunoreactivity in the rat brain. Am. J. Physiol 1996, 271:R1096-R1100.
250. van Rooij E., Fielitz J., Sutherland L.B., Thijssen V.L., Crijns H.J., Dimaio M.J., et al. Myocyte enhancer factor 2 and class II histone deacetylases control a gender-specific pathway of cardioprotection mediated by the estrogen receptor. Circ. Res 2010, 106(1):155-165.
251. Van Pelt R.E., Gozansky W.S., Schwartz R.S., Kohrt W.M. Intravenous estrogens increase insulin clearance and action in postmenopausal women. Am. J. Physiol. Endocrinol. Metab 2003, 285(2):E311-E317. PMCID: 2819703.
252. Vasconsuelo A., Milanesi L., Boland R. 17Beta-estradiol abrogates apoptosis in murine skeletal muscle cells through estrogen receptors: role of the phosphatidylinositol 3-kinase/Akt pathway. J. Endocrinol 2008, 196(2):385-397.
253. Vegeto E., Cuzzocrea S., Crisafulli C., Mazzon E., Sala A., Krust A., et al. Estrogen receptor-alpha as a drug target candidate for preventing lung inflammation. Endocrinology 2010, 151(1):174-184. PMCID: 2803150.
254. Villa A., Della Torre S., Stell A., Cook J., Brown M., Maggi A. Tetradian oscillation of estrogen receptor α is necessary to prevent liver lipid deposition. Proc. Natl. Acad. Sci. U.S.A. 2012, 109(29):11806-11811.
255. Voisin D.L., Simonian S.X., Herbison A.E. Identification of estrogen receptor-containing neurons projecting to the rat supraoptic nucleus. Neuroscience 1997, 78(1):215-228.
256. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr. Rev 2000, 21(6):697-738.
257. Wallen W.J., Belanger M.P., Wittnich C. Sex hormones and the selective estrogen receptor modulator tamoxifen modulate weekly body weights and food intakes in adolescent and adult rats. J. Nutr 2001, 131(9):2351-2357.
258. Wang F., He Q., Sun Y., Dai X., Yang X.P. Female adult mouse cardiomyocytes are protected against oxidative stress. Hypertension 2010, 55(5):1172-1178. PMCID: 2861855.
259. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest 2005, 115(5):1111-1119. PMCID: 1087185.
260. Wiik A., Gustafsson T., Esbjornsson M., Johansson O., Ekman M., Sundberg C.J., et al. Expression of oestrogen receptor alpha and beta is higher in skeletal muscle of highly endurance-trained than of moderately active men. Acta Physiol. Scand 2005, 184(2):105-112.
261. Wilkinson H.A., Dahllund J., Liu H., Yudkovitz J., Cai S.J., Nilsson S., et al. Identification and characterization of a functionally distinct form of human estrogen receptor beta. Endocrinology 2002, 143(4):1558-1561.
262. Wise P.M., Scarbrough K., Weiland N.G., Larson G.H. Diurnal pattern of proopiomelanocortin gene expression in the arcuate nucleus of proestrous, ovariectomized, and steroid-treated rats: a possible role in cyclic luteinizing hormone secretion. Mol. Endocrinol 1990, 4(6):886-892.
263. Wong W.P., Tiano J.P., Liu S., Hewitt S.C., Le May C., Dalle S., et al. Extranuclear estrogen receptor-alpha stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107(29):13057-13062. PMCID: 2919966.
264. Xu Y., Nedungadi T.P., Zhu L., Sobhani N., Irani B.G., Davis K.E., et al. Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction. Cell Metab 2011, 14(4):453-465.
265. Yamada Y., Ando F., Niino N., Ohta S., Shimokata H. Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density of the femoral neck in elderly Japanese women. J. Mol. Med 2002, 80(7):452-460.
266. Yang G., Badeanlou L., Bielawski J., Roberts A.J., Hannun Y.A., Samad F. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. Am. J. Physiol. Endocrinol. Metab 2009, 297(1):E211-E224.
267. Yang X., Deignan J.L., Qi H., Zhu J., Qian S., Zhong J., et al. Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks. Nat. Genet 2009, 41(4):415-423. PMCID: 2837947.
268. Yang Y.H., Ngo D., Jones M., Simpson E., Fritzemeier K.H., Morand E.F. Endogenous estrogen regulation of inflammatory arthritis and cytokine expression in male mice, predominantly via estrogen receptor alpha. Arthritis Rheum 2010, 62(4):1017-1025.
269. Yki-Jarvinen H. Sex and insulin sensitivity. Metabolism 1984, 33(11):1011-1015.
270. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372(6505):425-432.
271. Zhu L., Martinez M.N., Emfinger C.H., Palmisano B.T., Stafford J.M. Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity. Am. J. Physiol. Endocrinol. Metab 2014, 306:E1188-E1197.
272. Zorzano A., Palacin M., Guma A. Mechanisms regulating GLUT4 glucose transporter expression and glucose transport in skeletal muscle. Acta Physiol. Scand 2005, 183(1):43-58. PMCID: 15654919.